Growing occurrences of target conditions and advancement in biomedical technology are among the significant factors influencing the market growth.
The global biologics market is expected to reach USD 477.15 Billion by 2027, according to a new report by Emergen Research. The Biologics market is experiencing a rapid growth attributable to a growing demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, among others, in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Besides, growing demand and higher adoption of novel therapies across the globe for the treatment of disease conditions is a significant factor causative of the growing market demand.
Get a Sample Report at: https://www.emergenresearch.com/request-sample/61
The report provides extensive coverage of the market drivers, restraints, limitations, growth prospects, threats, opportunities, and current and emerging trends in the market. The report also offers an in-depth analysis of the market players along with their business overview, product portfolio, technological advancements, expansion plans, financial standing, and global position. It also sheds light on the collaborations in the competitive landscape
Key participants include Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., and GlaxoSmithKline, among others.
The report bifurcates the Biologics market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
The report discovers the market’s total sale that is generated by a particular firm over a time period. Industry experts calculate share by taking into account the product sales over a period and then dividing it by the overall sales of the Biologics industry over a defined period. Subject matter experts further use this metric to offer a general idea of the share and size of a firm and its immediate rivals. By providing an in-depth knowledge of the position a company, as well as an entrepreneur, holds in the Biologics market
Emergen Research has segmented the global biologics on the basis of source, type, application, and region:
Source Outlook (Revenue, USD Billion; 2017-2027)
Type Outlook (Revenue, USD Billion; 2017-2027)
- Monoclonal Antibodies
- Recombinant Hormones/Proteins
- Cellular-Based Biologics
- Gene-Based Biologics
Application Outlook (Revenue, USD Billion; 2017-2027)
- Infectious Diseases
- Immunological Diseases
- Cardiovascular Diseases
- Haematological Disorders
Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/61
Understanding the market size
The size of the Biologics market is viewed in terms of the Share of Market, Total Available Market as well as Served Available Market. Not only does the study present the combined revenue for a particular market but also the market size for a specific geographic region. Analysis of percentage or the size of the Total Available Market based on the type of product, technology, regional constraints and others form an important part of the Biologics report.
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Research Report on the Biologics Market Addresses the Following Key Questions:
- Who are the dominant players of the Biologics market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the Biologics market?
- What are the key growth drivers and restraining factors of the Biologics market?
- What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
- What is the overall impact of the COVID-19 pandemic on the Biologics market and its key segments?
Thank you for reading our report. Customization of the report is available according to the requirements of clients. In case of further queries about the report, do get in touch with us. Our team will make sure your report is tailored according to your needs.
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
State: British Columbia